EU PROJECTS PROMOTE EU BREAST CANCER PERSONALISED MEDICINES
November 1st, 2014
THE EUROPEAN Commission has highlighted a series of European Union (EU)-funded research projects aimed at making breast cancer treatments more effective through personalised medicine approaches. Notably, a communiqué stressed the value of the MINDACT trials, whose results will be available in 2015, assessing how genomic analysis can help physicians better target chemotherapy. The work is associated with the EU’s TRANSBIG project (http://www.bigagainstbreastcancer.org/), linking laboratory studies to medicine-based health treatment.The Commission also ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.